Accessibility Menu
Nutex Health logo

Nutex Health(NASDAQ) NUTX

Market Cap$1.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-97%
5 Year-61%
1 Year+82%
1 Month-10%
$161.44
+6.26%
+9.51Today
After hours$160.00-$1.44 (-0.89%)
Nutex Health last closing stock price
MetricPriceDate
Last closeUSD 162.072026-08-07
Nutex Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+9.93%USD 147.432026-07-31
1 month-9.74%USD 179.552026-07-08
3 month+18.59%USD 136.662026-05-08
Year to date-1.55%USD 164.622025-12-31
1 year+81.63%USD 89.232025-08-07
3 year+224.17%USD 50.002023-08-08
5 year-60.71%USD 412.502021-08-05
Since inception-97.3%USD 6,000.002022-04-04

Nutex Health Financials at a Glance

Market Cap

$1.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$846.72M

Net Income (TTM)

$179.92M

EPS (TTM)

$25.28

P/E Ratio

6.41

Dividend

$0.00

Beta (Volatility)

1.46 (Average)

Price

$161.44

Volume

294,765

Open

$164.75

Previous Close

$162.07

Daily Range

$152.38 - $173.00

52-Week Range

$77.21 - $204.00

Estimated Earnings Date

Aug 6, 2026

NUTX: Motley Fool Moneyball Superscore

56

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nutex Health

Nutex Health runs small hospitals and manages doctor networks across the U.S. Its hospitals treat urgent health issues close to home. The company helps doctors and patients by making care easier to access and manage.

What’s in the Nutex Toolbox?

  • Hospital Division (96.3% of revenue): Runs micro-hospitals, specialty hospitals, and outpatient departments for local patient care.
  • Population Health Management (3.7% of revenue): Manages doctor networks and supports physician groups with administrative services.
  • Cloud-Based Platform: Aggregates patient and provider data to improve care coordination and decision-making.
  • Billing and Collections: Handles insurance claims and payment processes for hospital services.
  • Real Estate: Owns and leases hospital buildings to its operating divisions.

Growth Moves: Nutex’s Expansion Playbook

  • Opened four new hospitals in 2024, bringing the total to 24 by March 2025.
  • Plans to open three more hospitals by the end of 2025.
  • Engaged a third-party vendor in July 2024 to support insurance claim arbitration.

Why Nutex Stands Out (Without the Hype)

Nutex focuses on small, physician-led hospitals and doctor networks, using technology to connect patient data. Its out-of-network model relies on insurance payments and a legal process to resolve billing disputes. The company’s growth comes from opening new hospitals and expanding doctor partnerships.

Five Things You Need to Know

  • Revenue was $211.8 million in Q1 2025, up 214% from Q1 2024.
  • Gross profit reached $118.3 million in Q1 2025, up from $10.2 million.
  • Net income was $14.6 million in Q1 2025, compared to a $0.4 million loss.
  • Patient visits rose 20.5% year-over-year to 48,269 in Q1 2025.
  • Cash and equivalents were $87.7 million as of March 31, 2025.

Bottom Line

Nutex has rapidly grown by expanding its hospital network and doctor partnerships. Its technology-driven, physician-led model aims to streamline care and insurance payments in a changing healthcare landscape.

AI Generated • Apr 16, 2026

Industry

Healthcare Providers and Services

Employees

1,317

CEO

Thomas T. Vo, MD, MBA

Headquarters

Houston, TX 77056, US

NUTX Financials

Key Financial Metrics (TTM)

Gross Margin

51.26%

Operating Margin

43.02%

Net Income Margin

21.25%

Return on Equity

47.97%

Return on Capital

40.48%

Return on Assets

18.65%

Earnings Yield

15.60%

Dividend Yield

0.00%

Payout Ratio

55.29%

Stock Overview

Market Cap

$1.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

6.88M

Volume

294.76K

Avg. Volume

129.81K

Financials (TTM)

Gross Profit

$434.03M

Operating Income

$364.27M

EBITDA

$353.83M

Operating Cash Flow

$355.14M

Capital Expenditure

-$6.65M

Free Cash Flow

$348.49M

Cash & ST Invst.

$205.21M

Total Debt

$316.13M

Nutex Health Performance Analysis

Nutex Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 219,294,306-33.9%
20232023-12-31USD 247,646,31612.9%
20242024-12-31USD 479,948,63393.8%
20252025-12-31USD 875,257,00082.4%
Nutex Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-309.8%
Q42025-12-31-43.4%
Q12026-03-3142.7%
Q22026-06-30-2.6%
Nutex Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -100.36N/A
20232023-12-31USD -10.39-89.7%
20242024-12-31USD 9.69N/A
20252025-12-31USD 10.488.1%
Nutex Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30357.0%
Q42025-12-31-79.1%
Q12026-03-31302.5%
Q22026-06-3040.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$210.75M

-13.6%

Gross Profit

$141.28M

+13.1%

Gross Margin

67.04%

N/A

Market Cap

$1.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.18M

N/A

Employees

944

N/A

Net Income

$65.84M

+472.1%

EBITDA

$96.60M

+178.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$205.21M

+112.1%

Total Debt

$316.13M

-8.4%

Accounts Receivable

$351.68M

-0.9%

Inventory

$4.21M

+84.9%

Long Term Debt

$298.13M

-3.6%

Short Term Debt

$18.01M

-49.9%

Return on Assets

18.65%

N/A

Return on Invested Capital

42.99%

N/A

Free Cash Flow

$105.98M

+299.8%

Operating Cash Flow

$109.72M

+302.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
REPLReplimune Group, Inc.
$12.06-6.22%
HSTMHealthStream, Inc.
$28.72+2.13%
AMNAMN Healthcare Services, Inc.
$36.00+16.88%
DNAGinkgo Bioworks Holdings, Inc.
$7.97-6.24%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$133.11+0.16%
TTDThe Trade Desk
$13.80-0.22%
NVDANvidia
$223.96+0.02%
TLTiShares Trust - iShares 20+ Year Treasury Bond ETF
$82.76+0.00%

Questions About NUTX

What is the current price of Nutex Health?

Nutex Health is trading at $162.07 per share.

What is the 52-week range for Nutex Health?

Over the past 52 weeks, Nutex Health has traded between $77.21 and $204.00.

How much debt does Nutex Health have?

As of the most recent reporting period, Nutex Health reported total debt of $347.34M.

How much cash does Nutex Health have on hand?

Nutex Health reported $207.11M in cash and cash equivalents in its most recent financial results.

What is Nutex Health’s dividend yield?

Nutex Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.